Sociedad Comercial del Plata S.A. (BCBA:COME)

Theseus Pharmaceuticals Balance Sheet

Financials in millions ARS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10,543	11,339	7,737	3,016	4,240	1,666
Short-Term Investments	38,189	45,604	105,623	36,057	4,012	1,321
Cash & Short-Term Investments	48,732	56,943	113,360	39,072	8,252	2,986
Cash Growth	8.30%	-49.77%	190.13%	373.46%	176.36%	107.02%
Accounts Receivable	39,659	28,935	41,364	13,030	4,783	2,407
Other Receivables	10,312	10,724	7,089	850.72	715.08	895.68
Receivables	49,971	39,659	48,459	14,315	5,498	3,303
Inventory	50,876	47,987	51,231	11,985	3,711	1,949
Other Current Assets	24,697	25,979	30,514	6,699	2,262	2,791
Total Current Assets	174,275	170,568	243,564	72,072	19,724	11,029
Property, Plant & Equipment	330,071	307,203	347,081	139,165	44,651	28,826
Long-Term Investments	164,543	144,818	73,403	75,740	28,998	14,368
Other Intangible Assets	9,454	7,407	8,498	3,737	1,406	826.9
Long-Term Deferred Tax Assets	861.99	658.74	123.9	171.29	710.14	286.49
Other Long-Term Assets	10,360	7,309	19,071	5,166	2,329	1,002
Total Assets	689,617	638,005	691,756	296,054	97,835	56,338
Accounts Payable	47,404	45,365	64,787	10,729	4,188	3,217
Accrued Expenses	16,214	17,163	14,003	6,393	1,766	861.52
Current Portion of Long-Term Debt	23,585	19,359	24,186	86.59	-	1,159
Current Portion of Leases	-	-	-	6.73	18.05	17.85
Current Income Taxes Payable	1,029	754.61	9,952	1,447	2,480	539.75
Current Unearned Revenue	-	6,297	-	-	-	-
Other Current Liabilities	12,103	6,400	21,794	5,448	3,366	3,252
Total Current Liabilities	100,336	95,339	134,723	24,110	11,819	9,046
Long-Term Debt	3,322	3,681	8,252	877.19	148.62	526.92
Long-Term Leases	-	-	-	3.36	25.09	-
Long-Term Deferred Tax Liabilities	79,408	75,181	104,935	43,868	13,629	6,092
Other Long-Term Liabilities	2,855	2,374	5,159	3,964	1,898	1,557
Total Liabilities	185,921	176,575	253,068	72,823	27,520	17,222
Common Stock	3,119	3,119	3,119	3,119	3,119	3,119
Retained Earnings	73,511	63,429	-2,232	37,826	9,598	4,329
Treasury Stock	-	-	-	-	-834.97	-428.64
Comprehensive Income & Other	417,321	386,017	428,720	182,286	58,434	29,752
Total Common Equity	493,951	452,565	429,607	223,231	70,315	36,771
Minority Interest	9,744	8,865	9,081	-	-	2,346
Shareholders' Equity	503,695	461,430	438,688	223,231	70,315	39,116
Total Liabilities & Equity	689,617	638,005	691,756	296,054	97,835	56,338
Total Debt	26,907	23,040	32,438	973.87	191.76	1,703
Net Cash (Debt)	21,824	33,903	80,923	38,098	8,061	1,283
Net Cash Growth	-21.02%	-58.10%	112.41%	372.65%	528.44%	-
Net Cash Per Share	7.08	11.00	25.73	12.21	2.55	0.44
Filing Date Shares Outstanding	3,119	3,119	3,119	3,119	3,119	3,119
Total Common Shares Outstanding	3,119	3,119	3,119	3,119	3,119	3,119
Working Capital	73,939	75,230	108,841	47,962	7,905	1,982
Book Value Per Share	158.37	145.10	137.74	71.57	22.54	11.79
Tangible Book Value	484,497	445,158	421,109	219,494	68,909	35,944
Tangible Book Value Per Share	155.34	142.72	135.01	70.37	22.09	11.52
Land	90,955	83,776	84,852	37,384	12,005	7,705
Buildings	135,788	126,201	132,396	53,786	17,274	10,236
Machinery	187,754	158,834	176,425	55,999	16,773	10,564
Construction In Progress	1,767	2,229	9,483	7,329	1,598	875.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.